Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ergomed PLC

Latest From Ergomed PLC

Appointments: IFPMA, German Merck, Ergomed, Spectrum, Astellas, Laboratoris Sanifit and Audentes Therapeutics

Appointment announcements this week include Greg Perry becoming the IFPMA’s new assistant director general, a new head of corporate affairs at German Merck, new CEOs at Ergomed and Spectrum, and other senior hires at Astella Americas, Laboratoris Sanifit, and a new board member at Audentes Therapeutics Inc.

Appointments BioPharmaceutical

Pipeline Watch: Risankizumab, Viaskin Peanut, Symtuza Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Approvals Pipeline Watch

Freeze Lift Allows Cel-Sci And Ergomed Motor On With Multikine

The biggest Phase III trial in head and neck cancer is resuming after the FDA lifted a freeze on trials evaluating CEL-SCI's lead asset Multikine in the indication, giving a boost to its commercial prospects.

Clinical Trials Companies

Appointments: Tiziana, Ergomed, Kymab, Crescendo, Ablynx, Axcella and Alexion.

This week's roundup includes CEO appointments by Tiziana and Ergomed and executive appointments by Crescendo Biologics, Ablynx, Alexion and Axcella. In addition to this, Oxford BioTherapeutics and Kymab have announced board appointments.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Ergomed PLC
  • Senior Management
  • Miroslav Reljanovic , MD, CEO
    Stephen Stamp, CFO
    Andrew Mackie, CBO
  • Contact Info
  • Ergomed PLC
    Phone: 1483 503 205
    26 Frederick Sanger Rd.
    Surrey , GU2 7YD